This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Cold Chain Logistics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Cold Chain Logistics. This report contains market size and forecasts of Biopharmaceutical Cold Chain Logistics in global, including the following market information:
- Global Biopharmaceutical Cold Chain Logistics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Biopharmaceutical Cold Chain Logistics market was valued at US$ 105.9 billion in 2022 and is projected to reach US$ 224.1 billion by 2030, at a CAGR of 7.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Airways Cold Chain Logistics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical Cold Chain Logistics include FedEx Corporation, Ceva Logistics LLC, Amerisource Bergen Corporation, Panalpina Group, Kuehne + Nagel International AG, XPO Logistics, Inc, United Parcel Service, Inc, Deutsche Post DHL Group and DB Schenker, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical Cold Chain Logistics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical Cold Chain Logistics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Biopharmaceutical Cold Chain Logistics Market Segment Percentages, by Type, 2022 (%)
- Airways Cold Chain Logistics
- Roadways Cold Chain Logistics
- Seaways Cold Chain Logistics
Global Biopharmaceutical Cold Chain Logistics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Biopharmaceutical Cold Chain Logistics Market Segment Percentages, by Application, 2022 (%)
- Food and Beverages
- Healthcare
- Others
Global Biopharmaceutical Cold Chain Logistics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Biopharmaceutical Cold Chain Logistics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biopharmaceutical Cold Chain Logistics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biopharmaceutical Cold Chain Logistics revenues share in global market, 2022 (%)
key players include:
- FedEx Corporation
- Ceva Logistics LLC
- Amerisource Bergen Corporation
- Panalpina Group
- Kuehne + Nagel International AG
- XPO Logistics, Inc
- United Parcel Service, Inc
- Deutsche Post DHL Group
- DB Schenker
- C.H. Robinson Worldwide
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biopharmaceutical Cold Chain Logistics, market overview.
- Chapter 2: Global Biopharmaceutical Cold Chain Logistics market size in revenue.
- Chapter 3: Detailed analysis of Biopharmaceutical Cold Chain Logistics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biopharmaceutical Cold Chain Logistics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
